CME Group Inc. $CME Stock Holdings Decreased by Troy Asset Management Ltd

Troy Asset Management Ltd decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 330,049 shares of the financial services provider’s stock after selling 12,833 shares during the period. CME Group comprises about 2.3% of Troy Asset Management Ltd’s investment portfolio, making the stock its 11th biggest holding. Troy Asset Management Ltd owned about 0.09% of CME Group worth $89,176,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Caldwell Trust Co lifted its holdings in CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after buying an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in CME Group in the third quarter worth $27,000. Financial Consulate Inc. bought a new stake in CME Group during the third quarter valued at $28,000. Sagard Holdings Management Inc. acquired a new stake in shares of CME Group during the second quarter worth $30,000. Finally, Corundum Trust Company INC bought a new position in shares of CME Group in the 3rd quarter worth about $30,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. This trade represents a 21.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Royal Bank Of Canada boosted their price objective on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft lifted their target price on CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. TD Cowen raised their price target on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Morgan Stanley upped their price objective on CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Jefferies Financial Group cut their target price on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research note on Monday, January 12th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $299.53.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

CME Group Stock Performance

Shares of CME stock opened at $303.07 on Friday. CME Group Inc. has a 12-month low of $244.43 and a 12-month high of $309.35. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. The firm has a market capitalization of $109.29 billion, a price-to-earnings ratio of 27.16, a price-to-earnings-growth ratio of 3.30 and a beta of 0.27. The business has a 50 day simple moving average of $279.82 and a 200 day simple moving average of $274.00.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.52 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is 44.80%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.